After animal sacrifice and tumor resections, histological analyses by anti-OX1R immunostaining revealed that the OX1R expression was not affected by OxA or gemcitabine or OxA plus gemcitabine treatments as compared to tumors resected from control mice (Figure 3B). The gene discussed is HCRTR1; the disease is neoplasm.